Toxemia Clinical Trials

3 recruiting

Toxemia Trials at a Glance

11 actively recruiting trials for toxemia are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Moscow, Pittsburgh, and Essen. Lead sponsors running toxemia studies include Botkin Hospital, Centre Hospitalier Universitaire, Amiens, and Alexandra Hospital, Athens, Greece.

Browse toxemia trials by phase

Treatments under study

About Toxemia Clinical Trials

Looking for clinical trials for Toxemia? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Toxemia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Toxemia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Phase 4

Treatment With Aspirin After Preeclampsia: TAP Trial

Cardiovascular DiseasesHypertensionPregnancy Complications+8 more
Malamo Countouris60 enrolled1 locationNCT06281665
Recruiting
Phase 4

LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia Prevention

Pregnancy ComplicationsPreeclampsiaPreeclampsia Severe+1 more
Alexandra Hospital, Athens, Greece100 enrolled1 locationNCT07361679
Recruiting
Not Applicable

Studies on Adsorption International Learning Initiative Global

HemodialysisCKD (Chronic Kidney Disease) Stage 5DInflammation Biomarkers+5 more
Botkin Hospital60 enrolled1 locationNCT07123909
Recruiting
Not Applicable

Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial

Pregnancy ComplicationsPreeclampsiaHypertensive Disorder of Pregnancy+1 more
University of Pittsburgh454 enrolled1 locationNCT05655936
Recruiting
Not Applicable

Prognostic Role of the Uremic Toxin Indoxyl Sulfate on Vascular and Cardiac Functions During Acute Kidney Injury

Vascular DysfunctionAcute Kidney InjuryUremic; Toxemia
Centre Hospitalier Universitaire, Amiens105 enrolled1 locationNCT05659589
Recruiting
Not Applicable

Different Dietary Patterns

Diet, HealthyEndotoxemia
University of Vienna16 enrolled1 locationNCT06147440
Recruiting
Phase 4

Immunomodulatory Effects of Dexamethasone, Tocilizumab and Anakinra During Experimental Human Endotoxemia

SepsisDexamethasoneNeuroinflammatory Response+4 more
Radboud University Medical Center52 enrolled1 locationNCT06624436
Recruiting
Not Applicable

Efficacy and Safety of Hemoperfusion With Polymyxin B in Septic Shock Associated With Severe Endotoxemia in Cardiac Surgery Patients (РМХ vs SS)

Multiple Organ Dysfunction With Severe Endotoxemia
Petrovsky National Research Centre of Surgery20 enrolled1 locationNCT04920565
Recruiting
Not Applicable

Functionality of Albumin in the Context of Hemodialysis

DialysisUremic; ToxemiaAlbumin+1 more
Universität Duisburg-Essen50 enrolled1 locationNCT06561191
Recruiting

The Preeclampsia Registry

PreeclampsiaHypertensive Disorder of PregnancyEclampsia+2 more
Preeclampsia Foundation20,000 enrolled1 locationNCT06377878
Recruiting

Toxicokinetics of Protein-bound Uremic Toxins in ESRD Patients

Renal DialysisUremic; ToxemiaPharmacokinetics
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University100 enrolled1 locationNCT05755503